Outcomes in Patients with Interstitial Lung Disease Receiving Programmed Cell Death Protein 1 (PD-1) Inhibitors

被引：0
|
作者：
Dobre, I. [1 ]
Frank, A. J. [2 ]
D'Silva, K. M. [2 ]
Okin, D. [2 ]
Sharma, A. [2 ]
Montesi, S. B. [2 ]
机构：
[1] Queens Univ, Sch Med, Kingston, ON, Canada
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2020年 / 201卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A7795
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Neurological Adverse Effects Due to Programmed Death (PD-1) Inhibitors
    Shi, Siyu
    Kanwar, Ruhi
    Varanasi, Vamsi
    Eisinger, Ella
    Thomas, Reena
    Moore, Justin
    NEUROLOGY, 2019, 92 (15)
  • [22] Compare the efficacy and safety of programmed cell death-1 (PD-1) and programmed cell death ligand-1 (PD-L1) inhibitors for advanced non-small cell lung cancer: a Bayesian analysis
    Liang, Jiaqi
    Li, Ming
    Sui, Qihai
    Hu, Zhengyang
    Bian, Yunyi
    Huang, Yiwei
    Zhan, Cheng
    Jiang, Wei
    Wang, Qun
    Tan, Lijie
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (04) : 1302 - +
  • [23] Evaluation of programmed cell death protein 1 (PD-1) expression as a prognostic biomarker in patients with clear cell renal cell carcinoma
    Kim, Kyu Seo
    Sekar, Rishi R.
    Patil, Dattatraya
    Dimarco, Michelle A.
    Kissick, Haydn T.
    Bilen, Mehmet A.
    Osunkoya, Adeboye O.
    Master, Viraj A.
    ONCOIMMUNOLOGY, 2018, 7 (04):
  • [24] Programmed Cell Death 1 (PD-1) Inhibitors in Renal Transplant Patients with Advanced Cancer: A Double-Edged Sword?
    Lai, Hung-Chih
    Lin, Ji-Fan
    Hwang, Thomas I. S.
    Liu, Ya-Fang
    Yang, An-Hang
    Wu, Chung-Kuan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (09)
  • [25] Immunotherapy efficacy of programmed cell death 1 (PD-1) versus programmed death ligand-1 (PD-L1) inhibitors in non-small cell lung cancer (NSCLC) patients: A systematic review and meta-analysis.
    Yang, Danrong
    Cui, Longgang
    Zhang, Yuzi
    Zhao, Zhengyi
    Bai, Yuezong
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [26] Discovery of peptide inhibitors targeting human programmed death 1 (PD-1) receptor
    Li, Qiao
    Quan, Lina
    Lyu, Jiankun
    He, Zenghui
    Wang, Xia
    Meng, Jiajia
    Zhao, Zhenjiang
    Zhu, Lili
    Liu, Xiaofeng
    Li, Honglin
    ONCOTARGET, 2016, 7 (40) : 64967 - 64976
  • [27] Maternal Programmed Cell Death Protein 1 (PD-1) Levels are Increased in Women with Preeclampsia.
    Wang, Yuping
    Gu, Yang
    Morgan, John
    Cooper, Danielle
    Lockhard, Claude
    Lockhard, Claude
    McCathran, Charles
    Lewis, David
    REPRODUCTIVE SCIENCES, 2019, 26 : 277A - 277A
  • [28] Prior irradiation results in elevated programmed cell death protein 1 (PD-1) in T cells
    Li, Deguan
    Chen, Renxiang
    Wang, Yi-Wen
    Fornace, Albert J., Jr.
    Li, Heng-Hong
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2018, 94 (05) : 488 - 494
  • [29] Programmed death-ligand 1 (PD-L1) and programmed cell death protein 1 (PD-1) expression in bladder cancer (BC): Differences in recurrent, progressive, and metastatic disease.
    Hegele, Axel
    Wahl, Franziska
    Rexin, Peter
    Nimphius, W.
    Hofmann, Rainer
    Haenze, Joerg
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [30] In vitro Interactions of Chicken Programmed Cell Death 1 (PD-1) and PD-1 Ligand-1 (PD-L1)
    Reddy, Vishwanatha R. A. P.
    Mwangi, William
    Sadigh, Yashar
    Nair, Venugopal
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2019, 9
12345